Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.79 - $1.91 $100,709 - $243,488
127,481 Added 6.24%
2,171,961 $1.78 Million
Q4 2022

Feb 14, 2023

BUY
$1.41 - $2.5 $1.25 Million - $2.21 Million
884,345 Added 76.23%
2,044,480 $3.19 Million
Q3 2022

Nov 14, 2022

BUY
$1.66 - $2.79 $7,557 - $12,702
4,553 Added 0.39%
1,160,135 $2 Million
Q2 2022

Aug 15, 2022

BUY
$1.44 - $3.98 $244,798 - $676,596
169,999 Added 17.25%
1,155,582 $2 Million
Q1 2022

May 16, 2022

BUY
$2.97 - $5.2 $394,252 - $690,274
132,745 Added 15.57%
985,583 $3.58 Million
Q4 2021

Feb 14, 2022

SELL
$4.99 - $7.46 $475,686 - $711,146
-95,328 Reduced 10.05%
852,838 $4.26 Million
Q3 2021

Nov 12, 2021

SELL
$7.16 - $9.69 $8.69 Million - $11.8 Million
-1,214,143 Reduced 56.15%
948,166 $6.79 Million
Q2 2021

Aug 16, 2021

BUY
$6.23 - $10.03 $2.47 Million - $3.98 Million
396,637 Added 22.46%
2,162,309 $20 Million
Q1 2021

May 17, 2021

BUY
$8.81 - $16.96 $3.89 Million - $7.48 Million
440,987 Added 33.29%
1,765,672 $16.4 Million
Q4 2020

May 17, 2021

SELL
$8.5 - $12.85 $320,756 - $484,907
-37,736 Reduced 2.77%
1,324,685 $11.7 Million
Q4 2020

Feb 16, 2021

BUY
$8.5 - $12.85 $3.37 Million - $5.09 Million
396,089 Added 40.99%
1,362,421 $12.1 Million
Q3 2020

Nov 16, 2020

SELL
$9.57 - $27.05 $1.14 Million - $3.22 Million
-118,907 Reduced 10.96%
966,332 $11.2 Million
Q2 2020

Aug 14, 2020

BUY
$7.14 - $31.69 $3.78 Million - $16.8 Million
529,562 Added 95.3%
1,085,239 $29.2 Million
Q1 2020

May 14, 2020

BUY
$2.98 - $14.09 $666,217 - $3.15 Million
223,563 Added 67.32%
555,677 $4.13 Million
Q4 2019

Feb 14, 2020

SELL
$1.97 - $3.72 $214,578 - $405,193
-108,923 Reduced 24.7%
332,114 $1.1 Million
Q3 2019

Nov 14, 2019

SELL
$2.05 - $3.02 $25,907 - $38,166
-12,638 Reduced 2.79%
441,037 $904,000
Q2 2019

Aug 15, 2019

BUY
$2.29 - $4.1 $1.04 Million - $1.86 Million
453,675 New
453,675 $1.33 Million

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $459M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.